Company Profile: Adherium Limited (ASX: ADR) operates as a digital health company. The Company provides technologies for medication use and remote patient management in chronic diseases. Adherium also develops and manufactures solutions to monitor and increase patient adherence to therapies. The company is headed by Mr. Arik Anderson, who is also the group Chief Executive Officer of the enterprise. The company’s registered office is in Melbourne, Australia.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500. Click here for your FREE Report